Trial Profile
A Pilot, Multicenter, Open Label, Non Comparative Study of the Safety and Efficacy of Floxin Otic Solution in the Treatment of Acute Otitis Media Twice Daily for Seven Days in Children With Tympanostomy Tubes.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 20 Feb 2024
Price :
$35
*
At a glance
- Drugs Ofloxacin (Primary)
- Indications Bacterial infections; Otitis media
- Focus Therapeutic Use
- Sponsors Daiichi Sankyo Inc
- 16 Nov 2008 New trial record.